Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

Avoiding Aldosterone Breakthrough in Hypertensive Diabetics: Role of Azelnidipine

Dr. Prem Aggarwal28 Dec 2020 12:30 PM IST

Azelnidipine may contribute to avoid the "aldosterone breakthrough" by its suppressive effects on aldosterone synthesis and secretion

Impact of Azelnidipine in reducing urinary albumin excretion and carotid atherosclerosis in type 2 diabetes patients: BOAT 2 study Review

Dr. Prem Aggarwal15 Dec 2020 12:45 PM IST

Hypertension and Diabetes Mellitus are the global health burden and strong risk factors for coronary artery disease (1). Impaired glucose tolerance...

Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review

Dr. Prem Aggarwal27 Nov 2020 12:45 PM IST

Hypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...

Single-pill Triple Drug combination of Perindopril, Indapamide, Amlodipine shows robust efficacy, safety in Indian patients: JAPI

Dr. Prem Aggarwal24 Nov 2020 10:00 AM IST

A triple-drug single-pill combination (SPC) containing Perindopril, Indapamide, and Amlodipine has shown excellent safety, efficacy as well as...

Role of Azelnidipine on management of BP in hypertensive Diabetics: Review

Dr. Prem Aggarwal4 Nov 2020 11:09 AM IST

Hypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to...

Hypertension: ACEIs more effective in BP control and central hemodynamic improvement than ARBs, finds KGMU study

Dr. Prem Aggarwal15 Oct 2020 12:04 PM IST

New Delhi: High Blood Pressure (BP) patients treated with ACEIs versus ARBs showed a more effective improvement with ACEIs in the majority of...

BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine

Dr. Prem Aggarwal13 Oct 2020 12:17 PM IST

Hypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal...

Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension?

Dr. Prem Aggarwal10 Oct 2020 10:30 AM IST

Hypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...

Acid suppressants in Cardiac Patients: Sneak Peak of Clinical Guidelines

Dr. Prem Aggarwal25 Sept 2020 11:02 AM IST

Cardiovascular diseases (CVD) encompass a range of congenital or acquired pathological conditions that affect the structure or function of the heart,...

Effects of Azelnidipine versus Amlodipine on LV Mass and Longitudinal Function in Hypertensive Patients with LVH

Dr. Prem Aggarwal19 Sept 2020 11:00 AM IST

Left ventricular hypertrophy (LVH) is the structural remodelling of the heart which is a serious consequence of systemic hypertension. It is a...

Growing role of Cadexomer Iodine in wound care: Review

Dr. Prem Aggarwal17 Sept 2020 11:30 AM IST

Iodine, a natural element of the halogen group, is an essential nutrient in the body. It possesses antiseptic properties and hence has been used...

Evidence-based review on the incidence of ACEIs induced cough published in Indian Heart Journal

Dr. Prem Aggarwal16 Sept 2020 11:45 AM IST

New Delhi: Angiotensin-converting enzyme inhibitors (ACEIs) are most often prescribed as the first-line treatment modality in hypertensive patients....

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok